Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer (Q66912724)
scientific article published on 01 April 1975
Language:
Current Data About Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer
(P31) (Q13442814)
(P248)
(P698) 1116104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1116104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, August 31, 2019

(P304) 1108-1115
(P248)
(P698) 1116104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1116104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, August 31, 2019

(P407) (Q1860)

(P433) 4
(P248)
(P698) 1116104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1116104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, August 31, 2019

(P478) 35
(P248)
(P698) 1116104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1116104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, August 31, 2019

(P577) Tuesday, April 1, 1975
(P248)
(P698) 1116104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1116104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, August 31, 2019

(P921) (Q422232)
(P887)

(Q128581)
(P887)

(Q18936)
(P887)

(Q238512)
(P887)

(Q162555)
(P248)
(P356) 10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z
(P854) https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z
(P813) Friday, September 29, 2023

(P953) https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z
(P248)
(P356) 10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z
(P854) https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z
(P813) Friday, September 29, 2023

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z
(P248)
(P356) 10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z
(P854) https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z
(P813) Friday, September 29, 2023

(P1433) (Q326041)
(P248)
(P698) 1116104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1116104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, August 31, 2019

(P1476) "Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer" (language: en)
(P248)
(P698) 1116104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1116104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, August 31, 2019

(P2093) M. De Lena
(P1545) 1
(P248)
(P698) 1116104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1116104
(P813) Tuesday, August 23, 2022

C. Brambilla
(P1545) 2
(P248)
(P698) 1116104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1116104
(P813) Tuesday, August 23, 2022

A. Morabito
(P1545) 3
(P248)
(P698) 1116104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1116104
(P813) Tuesday, August 23, 2022

G. Bonadonna
(P1545) 4
(P248)
(P698) 1116104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1116104
(P813) Tuesday, August 23, 2022

(P2860) (Q326097)
(P1545) 1
(P478) 15
(P304) 100
(P2093) Ahmann
(P577) Tuesday, January 1, 1974
(P248)
(P356) 10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z
(P854) https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z
(P813) Friday, September 29, 2023

(Q69744314)
(P1545) 6
(P248)
(P356) 10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z
(P854) https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z
(P813) Friday, September 29, 2023

(Q39921039)
(P1545) 7
(P248)
(P356) 10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z
(P854) https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z
(P813) Friday, September 29, 2023

(Q54017386)
(P1545) 8
(P248)
(P356) 10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z
(P854) https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z
(P813) Friday, September 29, 2023

(Q33466756)
(P1545) 12
(P248)
(P356) 10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z
(P854) https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z
(P813) Friday, September 29, 2023

(Q69548231)
(P1545) 16
(P248)
(P356) 10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z
(P854) https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z
(P813) Friday, September 29, 2023

(Q69590637)
(P1545) 19
(P248)
(P356) 10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z
(P854) https://api.crossref.org/works/10.1002/1097-0142(197504)35:4%3C1108::AID-CNCR2820350414%3E3.0.CO;2-Z
(P813) Friday, September 29, 2023

other details
description scientific article published on 01 April 1975

External Links
(P356) 10.1002/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z
(P698) 1116104